Frequent loss of p16 protein expression and high proliferative activity (Ki-67) in malignant melanoma from black Africans

Anticancer Research

Volumn 20, Issue 6 C, 2000, Pages 4857-4862

  Vuhahula, E ^a   Straume, O ^a   Akslen, L A ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Africans; Angiogenesis; Ki 67; Malignant melanoma; p16 protein

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16; PROTEIN P53;

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER SIZE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCER;

ADULT; AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MELANOMA; MICROCIRCULATION; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NORWAY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0034491518     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Malignant melanoma in South African Bantu
2. Malignant melanoma in the Igbos of Nigeria
3. Racial differences in melanoma incidence
4. Malignant melanoma in Black Americans: A trend toward improved survival
5. Malignant melanoma in the Ivory Coast. Epidemiologic and histo-prognostic aspects; Report of 195 cases
6. Expression of p53 protein in cutaneous melanoma
7. p53 immunoreactivity in human malignant melanoma and dysplastic naevi
8. MIB-1 proliferative activity is a significant prognostic factor in primary thick cuteneous melanomas
9. Expression of p53 protein in malignant melanomas as a prognostic indicator
10. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick melanoma
11. Loss of nuclear p16 expression correlates with increased tumour cell proliferation (Ki- 679 and poor prognosis in patients with vertical growth phase melanoma
12. The prognostic significance of tumour vascularity in intermediate thickness (0-76-4.0 mm thick) skin melanoma
13. Angiogenesis colleration with metastases in melanoma
14. Angiogenesis is prognostically important in vertical growth-phase melanomas
15. Thickness, cross-sectional area and depth of invasion in the prognosis of cutenous melanoma
16. The histogenesis and biological behavior of primary human malignant melanomas of the skin
17. Independent prognostic importance in vascular invasion in nodular melanomas
18. Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma
19. Subungual malignant melanoma: Clinicopathological features of 100 cases
20. New concepts of surgical pathology of skin
21. Acral lentigenous melanoma
22. Importance of vascular endothelial growth factor (VEGF) and Thrombospondin-1 (TSP-1) in melanoma angiogenesis, and independent prognostic significance of microvessel density
23. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin
24. Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type
25. Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome
26. Prognostic significance of p53 in thin melanomas
27. Impact of p 16 expression on surgical management of malignant melanoma and pancreatic carcinoma
28. Loss of expression of the p 16 gene is frequent in malignant skin tumours
29. Alterations and prognostic significance of p 16 and p53 protein expression in subgroup of cuteneous melanoma